Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Assunto principal
Intervalo de ano de publicação
1.
Materials (Basel) ; 17(1)2023 Dec 29.
Artigo em Inglês | MEDLINE | ID: mdl-38204043

RESUMO

Atomistic simulations on the creep of a nickel-based single-crystal superalloy are performed for examining whether the so-called rhenium effect can be tuned by changing the spatial distribution of rhenium in the nickel matrix phase. Results show that Rhenium dopants at {100} phase interfaces facilitate mobile partial dislocations, which intensify the creep, leading to a larger creep strain than that of a pure Ni/Ni3Al system containing no alloying dopants. If all the Re dopants in the matrix phase are far away from phase interfaces, a conventional retarding effect of Re can be observed. The current study implies a tunable Re effect on creep via dislocation triggering at the phase interfaces.

2.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(4): 1245-1250, 2020 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-32798406

RESUMO

OBJECTIVE: To evaluate the value of serum free light chain (sFLC) κ/λ ratio (sFLCR) on the diagnosis and prognosis of patients with newly diagnosed multiple myeloma(MM), and explore the effect of sFLCR normalization on the prognosis of patients after 4 courses of induction therapy. METHODS: The clinical data of 43 newly diagnosed MM patients from January 2014 to January 2019 were analyzed retrospectively. Immunoturbidimetry was used to detect the expression levels of sFLC κ and λ. According to the ratio of involved and uninvolved sFLC, using 100 as a boundary, the MM patients were divided into the high ratio group (sFLCR≥100 or ≤0.01) and the low ratio group (0.010.05). CONCLUSION: Patients in the high ratio group at the initial diagnosis have worse renal function, later stage of disease, lower deep remission rate, earlier disease progression, shorter survival time, and worse clinical prognosis.


Assuntos
Mieloma Múltiplo/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica , Humanos , Cadeias Leves de Imunoglobulina , Prognóstico , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA